This method accounted for factors such as age, gender, race, comorbidities, medications, and laboratory data, including HbA1c, blood pressure, lipids, and BMI to provide insights into their roles as risk factors in the outcomes of interest
One would hope, he says, that some of that reduced expense would be passed on to consumers. Today, injectable GLP-1 medications can run about $500 per month for patients paying out-of-pocket
Kidney function requires monitoring in patients taking both agents, as topiramate reduces renal bicarbonate reabsorption and GLP-1 drugs lower fluid intake through appetite suppression
Safety outcomes were seldom reported in the RWE studies due to limitation of data collection
No comparable effects have been observed for other vitamin deficiencies such as thiamin and vitamin C
(2018) Tesamorelin Falutz J, Allas S, Blot K, et al